Skip to content

Study · Not a test of the peptide alone · 2011

1 result

Taylor dispersion analysis compared to dynamic light scattering for the size analysis of therapeutic peptides and proteins and their aggregates.

Hawe A, Hulse WL, Jiskoot W, Forbes RT

Pharmaceutical research11 May 2011Cited by 152 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Oxytocin.

  1. 01LabNot a test of Oxytocin aloneIn vitro (cell-free)Other

    Taylor dispersion analysis could size the small peptide oxytocin, which dynamic light scattering could not.

    In plain wordsIn lab tests, one size-measuring method could measure the small peptide oxytocin, and another method could not.

    Peptide
    Oxytocin
    Outcome
    Not applicableSizing of oxytocin by Taylor dispersion analysis versus dynamic light scattering
    Study

    n: not reported in source

    Oxytocin solution
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    Advantageously, TDA was also able to size the small peptide oxytocin, which was not feasible by DLS.
    1 context sentence
    Summary · context
    The hydrodynamic radius of oxytocin, bovine serum albumin, various monoclonal antibodies (type IgG) and etanercept at concentrations between 0.05 and 50 mg/ml was determined by TDA and DLS.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 01:30 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.